Plain-English translation of NCT07050888 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Type 1 Diabetes Mellitus research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers are testing whether inulin—a natural fiber that acts as a 'prebiotic' to feed healthy gut bacteria—can help people with type 1 diabetes keep their blood sugar in a safer range more often. This treatment comes as a powder you mix with water and drink once daily for 90 days. Half of the participants will receive inulin while the other half receive a placebo (a non-active powder) to see if the real treatment makes a measurable difference.
People with type 1 diabetes often struggle to keep their blood sugar stable throughout the day. Scientists believe that the bacteria in your gut may play a role in how your body controls blood sugar, so this medication—which feeds beneficial gut bacteria—might help improve that control and reduce dangerous blood sugar swings.
You likely qualify if…
You likely don't qualify if…
You would take a daily powder supplement (either inulin or placebo) mixed with water for 90 days, with visits at the beginning and end of the study. Researchers will check your blood sugar patterns, collect stool and urine samples to study your gut bacteria, answer questions about your quality of life and any digestive symptoms, and measure how your body's immune system responds. Neither you nor the researchers will know which treatment you're receiving until the study ends—this helps ensure fair results.
AI-generated summary from trial data · Jun 10, 2026 · Not medical advice
Netherlands